AU680370B2 - Pyrazolo(1,5-a)pyrimidine derivative - Google Patents

Pyrazolo(1,5-a)pyrimidine derivative Download PDF

Info

Publication number
AU680370B2
AU680370B2 AU25765/95A AU2576595A AU680370B2 AU 680370 B2 AU680370 B2 AU 680370B2 AU 25765/95 A AU25765/95 A AU 25765/95A AU 2576595 A AU2576595 A AU 2576595A AU 680370 B2 AU680370 B2 AU 680370B2
Authority
AU
Australia
Prior art keywords
phenyl
halogen
alkyl
lower alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25765/95A
Other languages
English (en)
Other versions
AU2576595A (en
Inventor
Kinji Hashimoto
Makoto Inoue
Masayuki Ohara
Takashi Okamura
Yasuo Shoji
Tsuneo Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2576595A publication Critical patent/AU2576595A/en
Application granted granted Critical
Publication of AU680370B2 publication Critical patent/AU680370B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU25765/95A 1994-06-21 1995-06-05 Pyrazolo(1,5-a)pyrimidine derivative Ceased AU680370B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP13863594 1994-06-21
JP7-53997 1995-03-14
JP6-138635 1995-03-14
JP5399795 1995-03-14
PCT/JP1995/001104 WO1995035298A1 (en) 1994-06-21 1995-06-05 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE

Publications (2)

Publication Number Publication Date
AU2576595A AU2576595A (en) 1996-01-15
AU680370B2 true AU680370B2 (en) 1997-07-24

Family

ID=26394734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25765/95A Ceased AU680370B2 (en) 1994-06-21 1995-06-05 Pyrazolo(1,5-a)pyrimidine derivative

Country Status (13)

Country Link
US (1) US5707997A (cg-RX-API-DMAC7.html)
EP (1) EP0714898B1 (cg-RX-API-DMAC7.html)
KR (1) KR100315837B1 (cg-RX-API-DMAC7.html)
CN (1) CN1046730C (cg-RX-API-DMAC7.html)
AT (1) ATE208776T1 (cg-RX-API-DMAC7.html)
AU (1) AU680370B2 (cg-RX-API-DMAC7.html)
CA (1) CA2169719C (cg-RX-API-DMAC7.html)
DE (1) DE69523864T2 (cg-RX-API-DMAC7.html)
DK (1) DK0714898T3 (cg-RX-API-DMAC7.html)
ES (1) ES2164153T3 (cg-RX-API-DMAC7.html)
PT (1) PT714898E (cg-RX-API-DMAC7.html)
TW (1) TW307767B (cg-RX-API-DMAC7.html)
WO (1) WO1995035298A1 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843951A (en) * 1995-09-28 1998-12-01 Otsuka Pharmaceutical Factory Inc. Analgesic composition of pyrazolo(1,5-A) pyrimidines
US6664261B2 (en) * 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
AU747708B2 (en) * 1996-07-24 2002-05-23 Du Pont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
BR9808845A (pt) * 1997-03-14 2000-08-01 Otsuka Pharma Co Ltd Derivado de pirimidina, agentes para a cura de uma doença alérgica, da asma e de uma dermatite atópica, agentes para inibição da produção de no de tnf-alfa, de citoquinas e da 5-lipoxigenase, processos para curar uma doença alérgica, a asma e uma dermatite atópica e para inibir a produção de no, de tnf-alfa e de citoquinas e a 5-lipoxigenase e usos de um composto
AU2321000A (en) * 1999-01-29 2000-08-18 Sumitomo Chemical Company, Limited Fat accumulation inhibitory agents
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
AU4203500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US20020061897A1 (en) 2000-03-30 2002-05-23 Elliott Richard L. Neuropeptide Y antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1506196B1 (en) * 2001-11-01 2012-01-18 Icagen, Inc. Pyrazolopyrimidines as sodium channel inhibitors
US20040028716A1 (en) * 2002-06-14 2004-02-12 Marks Andrew R. Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation
US7205308B2 (en) 2002-09-04 2007-04-17 Schering Corporation Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
DE60313872T2 (de) 2002-09-04 2008-01-17 Schering Corp. Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
US7119200B2 (en) 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
KR20050058507A (ko) 2002-09-04 2005-06-16 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘
KR20050057139A (ko) 2002-09-04 2005-06-16 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘
US7161003B1 (en) * 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
EP1545533A1 (en) 2002-09-04 2005-06-29 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US8673924B2 (en) 2002-09-04 2014-03-18 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US7196078B2 (en) 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
RU2380369C9 (ru) 2002-09-04 2011-07-10 Шеринг Корпорейшн Новые пиразолопиримидины как ингибиторы циклин-зависимой киназы
US8580782B2 (en) 2002-09-04 2013-11-12 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US6949895B2 (en) * 2003-09-03 2005-09-27 Axcelis Technologies, Inc. Unipolar electrostatic quadrupole lens and switching methods for charged beam transport
AR049769A1 (es) * 2004-01-22 2006-09-06 Novartis Ag Derivados de pirazolo(1,5-a)pirimidin 7-il-amina para utilizarse en el tratamiento de enfermedades dependientes de la quinasa de proteina
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
GB0519957D0 (en) 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
TW200639163A (en) 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods
EP1856119A1 (de) * 2005-03-01 2007-11-21 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
WO2006092428A2 (de) * 2005-03-02 2006-09-08 Basf Aktiengesellschaft 2-substituierte 7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
KR20110084339A (ko) 2005-07-09 2011-07-21 아스트라제네카 아베 당뇨병 치료에 있어 glk 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
CA2621983A1 (en) * 2005-09-09 2007-03-22 Schering Corporation Azafused cyclin dependent kinase inhibitors
PE20070543A1 (es) 2005-10-06 2007-06-14 Schering Corp Pirazolopirimidinas como inhibidores de protein quinasas
CA2670636A1 (en) * 2006-11-27 2008-06-05 H. Lundbeck A/S Heteroaryl amide derivatives
CN103204852A (zh) * 2007-04-10 2013-07-17 H.隆德贝克有限公司 作为p2x7拮抗剂的杂芳基酰胺类似物
WO2010116176A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
KR20140077963A (ko) 2011-10-20 2014-06-24 글락소스미스클라인 엘엘씨 시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체
US20140288052A1 (en) * 2011-10-20 2014-09-25 GlaxoSmithKline, LLC Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
EP3087074A1 (en) * 2013-12-23 2016-11-02 Norgine BV Benzene sulfonamides as ccr9 inhibitors
JP2017501145A (ja) 2013-12-23 2017-01-12 ノージン ビーブイ Ccr9調節因子として有用な化合物
WO2015143652A1 (en) * 2014-03-26 2015-10-01 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF
KR20250174699A (ko) * 2018-10-30 2025-12-12 크로노스 바이오, 인코포레이티드 Cdk9 활성을 조절하기 위한 화합물, 조성물 및 방법
CN119661538B (zh) * 2024-11-06 2025-10-17 中国科学院精密测量科学与技术创新研究院 一种吡唑并[3,4-d]嘧啶-4-酮类衍生物及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925385A (en) * 1972-04-20 1975-12-09 Icn Pharmaceuticals 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
JPH03204877A (ja) * 1989-10-25 1991-09-06 Otsuka Pharmaceut Factory Inc ピラゾロ[1,5―a]ピリミジン誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792533A (fr) * 1971-12-09 1973-06-08 Int Chem & Nuclear Corp Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation
JPS6157587A (ja) * 1984-08-29 1986-03-24 Shionogi & Co Ltd 縮合複素環誘導体および抗潰瘍剤
US4950585A (en) * 1987-08-18 1990-08-21 Konica Corporation Coupler for photographic use
DE69130683T2 (de) * 1991-04-22 1999-05-06 Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL
ES2148179T3 (es) * 1991-09-06 2000-10-16 Yoshitomi Pharmaceutical Compuesto de 4-amino(alquil)ciclohexan-1-carboxamida y uso del mismo.
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925385A (en) * 1972-04-20 1975-12-09 Icn Pharmaceuticals 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
JPH03204877A (ja) * 1989-10-25 1991-09-06 Otsuka Pharmaceut Factory Inc ピラゾロ[1,5―a]ピリミジン誘導体

Also Published As

Publication number Publication date
KR100315837B1 (ko) 2002-02-28
ATE208776T1 (de) 2001-11-15
PT714898E (pt) 2002-04-29
CN1131948A (zh) 1996-09-25
DE69523864T2 (de) 2002-06-13
CA2169719A1 (en) 1995-12-28
AU2576595A (en) 1996-01-15
DK0714898T3 (da) 2002-03-18
TW307767B (cg-RX-API-DMAC7.html) 1997-06-11
CN1046730C (zh) 1999-11-24
KR960703919A (ko) 1996-08-31
CA2169719C (en) 2002-04-16
DE69523864D1 (de) 2001-12-20
WO1995035298A1 (en) 1995-12-28
US5707997A (en) 1998-01-13
EP0714898A1 (en) 1996-06-05
EP0714898B1 (en) 2001-11-14
ES2164153T3 (es) 2002-02-16
EP0714898A4 (en) 1997-04-02

Similar Documents

Publication Publication Date Title
EP0714898B1 (en) PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE
US5977118A (en) 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions and methods of use thereof
EP0674641B1 (en) Pyrrolopyrimidines as crf antagonists
US7214676B2 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
RU2124511C1 (ru) Производные пиперазина
JP4409174B2 (ja) Gaba受容体のためのリガンドとしてのイミダゾ−ピリミジン誘導体
EP0539086A2 (en) Condensed pyrimidine derivatives and their use as angiotensine II antagonists
SK193489A3 (en) Bis(hydroxymethyl)cyclobutylpurines and -pyrimidines, method of their preparation and use
CA2206080A1 (en) Analgesic composition_of pryazolo{1,5-a}pyrimidine derivatives
RU2198885C2 (ru) Производные трициклического триазолобензазепина, способы их получения, фармацевтическая композиция и способ лечения аллергических заболеваний, промежуточные соединения и способы их получения
EP0077983B1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
KR20010006143A (ko) 화합물
DE69717453T2 (de) Amid derivate
JPWO1997046560A1 (ja) アミド誘導体
HU203238B (en) Process for producing antiinflammatory tricyclic oxindole derivatives
Campos et al. 5-fluorouracil derivatives. 1. Acyclonucleosides through a tin (IV) chloride-mediated regiospecific ring opening of alkoxy-1, 4-diheteroepanes
US5985882A (en) Pyrazolo[1,5-a]pyrimidine derivatives
JP3163413B2 (ja) 鎮痛剤
JP3163412B2 (ja) ピラゾロ〔1,5−a〕ピリミジン誘導体
US6288070B1 (en) Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine A3 receptor compatibilizing agent, and asthmatic remedy
EP4511375A1 (en) Bicyclic compounds
AU690090C (en) Pyrrolopyrimidines as CRF antagonists
KR20020046285A (ko) 트리아조로푸린 유도체,그 유도체를 함유하는 의약 조성물및 아데노신 에이 3 수용체 친화제
JPWO1996032394A1 (ja) ピラゾロ[1,5−a]ピリミジン誘導体
HK1003031B (en) Condensed pyrimidine derivatives and their use as angiotensine ii antagonists